Chih‐Yu Peng

1.3k total citations
37 papers, 1.0k citations indexed

About

Chih‐Yu Peng is a scholar working on Cancer Research, Periodontics and Molecular Biology. According to data from OpenAlex, Chih‐Yu Peng has authored 37 papers receiving a total of 1.0k indexed citations (citations by other indexed papers that have themselves been cited), including 13 papers in Cancer Research, 12 papers in Periodontics and 11 papers in Molecular Biology. Recurrent topics in Chih‐Yu Peng's work include Oral Health Pathology and Treatment (12 papers), MicroRNA in disease regulation (9 papers) and Head and Neck Cancer Studies (8 papers). Chih‐Yu Peng is often cited by papers focused on Oral Health Pathology and Treatment (12 papers), MicroRNA in disease regulation (9 papers) and Head and Neck Cancer Studies (8 papers). Chih‐Yu Peng collaborates with scholars based in Taiwan, China and Italy. Chih‐Yu Peng's co-authors include Cheng‐Chia Yu, Yi‐Wen Liao, Ming‐Yung Chou, Ming‐Yi Lu, Pei‐Ling Hsieh, Chuan‐Hang Yu, Yu‐Chao Chang, Shun‐Fa Yang, Yung‐Chuan Ho and Pei‐Yin Chen and has published in prestigious journals such as Journal of Clinical Oncology, International Journal of Molecular Sciences and Molecules.

In The Last Decade

Chih‐Yu Peng

36 papers receiving 996 citations

Peers

Chih‐Yu Peng

PERIO

ONCOL

PFM

Jeff Yi‐Fu Chen Taiwan

Ching‐Yu Yen Taiwan

S. De Maria Italy

Yung‐Chuan Ho Taiwan

Ping Pei United States

Wings TY Loo China

Ki‐Rim Kim South Korea

Sadhna Aggarwal India

Isabella Gigante Italy

Silvia Taveira Elias Brazil

Jeff Yi‐Fu Chen Taiwan

Chih‐Yu Peng

386 ×0.7

116 ×0.3

73 ×0.3

PERIO

111 ×0.8

ONCOL

76 ×0.8

PFM

Citations per year, relative to Chih‐Yu Peng Chih‐Yu Peng (= 1×) peers Jeff Yi‐Fu Chen

Countries citing papers authored by Chih‐Yu Peng

Since Specialization

Citations

This map shows the geographic impact of Chih‐Yu Peng's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Chih‐Yu Peng with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Chih‐Yu Peng more than expected).

Fields of papers citing papers by Chih‐Yu Peng

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Chih‐Yu Peng. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Chih‐Yu Peng. The network helps show where Chih‐Yu Peng may publish in the future.

Co-authorship network of co-authors of Chih‐Yu Peng

This figure shows the co-authorship network connecting the top 25 collaborators of Chih‐Yu Peng. A scholar is included among the top collaborators of Chih‐Yu Peng based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Chih‐Yu Peng. Chih‐Yu Peng is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Lu, Hsueh‐Ju, Chao‐Yu Shen, Wea‐Lung Lin, et al.. (2024). Radiomic biomarkers for platinum‐refractory head and neck cancer in the era of immunotherapy. Oral Diseases. 30(7). 4220–4230. 2 indexed citations

Yu, Cheng‐Chia, Pei‐Ling Hsieh, Yi‐Wen Liao, et al.. (2024). Carvacrol inhibits the progression of oral submucous fibrosis via downregulation of PVT1/miR‐20a‐5p‐mediated pyroptosis. Journal of Cellular and Molecular Medicine. 28(18). e70112–e70112. 1 indexed citations

Lu, Hsueh‐Ju, Chih‐Yu Peng, Hsien‐Chun Tseng, et al.. (2024). Parameters to assess the necessity of adjuvant therapy for early‐stage oral squamous cell carcinoma. Oral Diseases. 31(3). 756–768. 2 indexed citations

Yang, Cheng‐Chieh, Cheng‐Hsien Wu, Yu-Hsien Lee, et al.. (2022). Improving the Diagnostic Performance by Adding Methylation Marker to Conventional Visual Examination in Identifying Oral Cancer. Diagnostics. 12(7). 1544–1544. 4 indexed citations

Lu, Ming‐Yi, Chih‐Yu Peng, & Yu‐Chao Chang. (2022). Interns’ perception of haptic virtual reality oral surgery simulator learning for impacted lower third molar extraction. Journal of Dental Sciences. 17(4). 1825–1826. 6 indexed citations

Lu, Hsueh‐Ju, Chih‐Yu Peng, Hsien‐Chun Tseng, et al.. (2022). Prediction Model of Distant Metastasis in Oral Cavity Squamous Cell Carcinoma With or Without Regional Lymphatic Metastasis. Frontiers in Oncology. 11. 713815–713815. 4 indexed citations

Lu, Hsueh‐Ju, Chih‐Yu Peng, Hsien‐Chun Tseng, et al.. (2022). Preoperative prediction model to evaluate salvage surgery in patients with recurrent or second primary oral cavity squamous cell carcinoma. Oral Oncology. 131. 105951–105951. 3 indexed citations

Yang, Cheng‐Chieh, Chung‐Ji Liu, Cheng‐Hsien Wu, et al.. (2021). Is OLP potentially malignant? A clue from ZNF582 methylation. Oral Diseases. 29(3). 1282–1290. 6 indexed citations

Peng, Chih‐Yu, Cheng‐Chia Yu, Yi‐Wen Liao, et al.. (2021). Magnolol inhibits cancer stemness and IL-6/Stat3 signaling in oral carcinomas. Journal of the Formosan Medical Association. 121(1). 51–57. 28 indexed citations

10.

Yu, Cheng‐Chia, Chih‐Yu Peng, Yi‐Wen Liao, et al.. (2021). Silencing periostin inhibits myofibroblast transdifferentiation of fibrotic buccal mucosal fibroblasts. Journal of the Formosan Medical Association. 120(11). 2010–2015. 5 indexed citations

11.

Chen, Pei‐Yin, et al.. (2020). LncRNA MEG3 inhibits self-renewal and invasion abilities of oral cancer stem cells by sponging miR-421. Journal of the Formosan Medical Association. 120(4). 1137–1142. 30 indexed citations

12.

Chen, Yi‐Tzu, et al.. (2020). Preservation of Inferior Alveolar Nerve Using the Dynamic Dental Implant Navigation System. Journal of Oral and Maxillofacial Surgery. 78(5). 678–679. 14 indexed citations

13.

Su, Shih‐Chi, Lun‐Ching Chang, Hsien‐Da Huang, et al.. (2020). Oral microbial dysbiosis and its performance in predicting oral cancer. Carcinogenesis. 42(1). 127–135. 103 indexed citations

14.

Liao, Yi‐Wen, et al.. (2019). Arctigenin Reduces Myofibroblast Activities in Oral Submucous Fibrosis by LINC00974 Inhibition. International Journal of Molecular Sciences. 20(6). 1328–1328. 37 indexed citations

15.

Lu, Ming‐Yi, Cheng‐Chia Yu, Pei‐Yin Chen, et al.. (2018). miR-200c inhibits the arecoline-associated myofibroblastic transdifferentiation in buccal mucosal fibroblasts. Journal of the Formosan Medical Association. 117(9). 791–797. 30 indexed citations

16.

Peng, Chih‐Yu, Yi‐Wen Liao, Ming‐Yi Lu, et al.. (2017). Downregulation of miR-1 enhances tumorigenicity and invasiveness in oral squamous cell carcinomas. Journal of the Formosan Medical Association. 116(10). 782–789. 24 indexed citations

17.

Lin, Che-Yi, Yi‐Wen Liao, Pei‐Ling Hsieh, et al.. (2017). LncRNA GAS5-AS1 inhibits myofibroblasts activities in oral submucous fibrosis. Journal of the Formosan Medical Association. 117(8). 727–733. 43 indexed citations

18.

Peng, Chih‐Yu, Hui‐Wen Yang, Yu‐Chao Chang, et al.. (2012). Caffeic Acid Phenethyl Ester Inhibits Oral Cancer Cell Metastasis by Regulating Matrix Metalloproteinase-2 and the Mitogen-Activated Protein Kinase Pathway. Evidence-based Complementary and Alternative Medicine. 2012. 1–10. 40 indexed citations

19.

Peng, Chih‐Yu, Yu‐Feng Huang, Ming‐Yi Lu, Yu-Hsien Lee, & Chuan‐Hang Yu. (2012). Intraosseous verrucous carcinoma arising from an infected dentigerous cyst—A case report. Journal of the Formosan Medical Association. 114(8). 764–768. 5 indexed citations

20.

Ng, Yan‐Yan, et al.. (2010). Successful Weaning of a Laryngeal Mask Airway After a Tongue-lip Adhesion Operation in a Case With Cerebro-costo-mandibular Syndrome. Pediatrics & Neonatology. 51(1). 57–60. 5 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact